Analyst Price Target is C$0.00
This price target is based on 1 analysts offering 12 month price targets for Aurinia Pharmaceuticals in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$0.00. The average price target represents a NaN upside from the last price of C$0.00.
Current Consensus is
The current consensus among 1 investment analysts is to buy stock in Aurinia Pharmaceuticals. This Buy consensus rating has held steady for over two years.